Sources and small print

1. Results are based on the STEP 1 Wegovy trial. Results vary – weight loss can be more or less than the 15% average.

Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" New England Journal of Medicine, 384(11)

https://doi.org/10.1056/NEJMoa2032183

* Terms and conditions apply.

** Price may increase or decrease subject to market conditions.

*** Coming soon

**** Maximum of one consultation per week with no carry-over of unused appointments.

***** An admin fee may apply for early cancellation. See our terms and conditions.